Study guide
11.2 Dermatology, Ophthalmology & ENT
APC Intern Written Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Pathway to General Registration 1.3 Restricted Open-Book Strategy (AMH & APF) 1.4 Scoring, Results & Appeals
2 Legal Framework: PBS & Medicine Schedules
2.1 PBS, Authority Prescriptions & Special Access Scheme 2.2 Schedules 2 & 3 (Pharmacy & Pharmacist Only Medicines) 2.3 Schedules 4 & 8 (Prescription Only & Controlled Drugs)
3 Legal Framework: Privacy, National Law & Pharmacy Board
3.1 Privacy, Confidentiality & Patient Rights 3.2 Health Practitioner National Law & Registration 3.3 Pharmacy Board Codes, Guidelines & Standards
4 Patient-Centred Medication Management
4.1 Assessing Clinical Situations & Treatment Options 4.2 Patient Factors: Adherence, Efficacy & Safety 4.3 Drug & Dosage-Form Factors 4.4 Culturally Responsive Medication Management
5 Primary Care & Judicious Use of Medicines
5.1 Primary Care & OTC Assessment 5.2 Judicious Use of Antimicrobials & High-Risk Agents 5.3 Non-Pharmacological Options & Evidence-Based OTC Choices
6 Dispensing & Clinical Appropriateness
6.1 Prescription Evaluation 6.2 Clinical Appropriateness Checks 6.3 Labelling, Packaging & Dispensing Standards 6.4 Communicating with Prescribers & Documenting Changes
7 Counselling & Acute Care
7.1 Patient-Centred Counselling 7.2 Confirming Understanding & Lifestyle Counselling 7.3 Acute Illness, Injury & Emergency Response
8 Therapeutics: Cardiovascular & Endocrine
8.1 Hypertension & Heart Failure 8.2 Ischaemic Heart Disease & Anticoagulation 8.3 Diabetes Medicines 8.4 Thyroid & Lipid Disorders
9 Therapeutics: Infection, Respiratory & Gastrointestinal
9.1 Anti-Infectives & Infection Management 9.2 Asthma & COPD 9.3 Gastrointestinal & Hepatic Conditions 9.4 Vaccination & Travel Health
10 Therapeutics: Neurology, Psychiatry & Pain
10.1 Epilepsy & Movement Disorders 10.2 Depression, Anxiety & Psychosis 10.3 Pain Management & Opioids 10.4 Migraine & Common Analgesics
11 Therapeutics: Special Populations & Systems
11.1 Women's Health, Contraception & Pregnancy 11.2 Dermatology, Ophthalmology & ENT 11.3 Renal/Hepatic Impairment & Dose Adjustment
12 Therapeutics: Rheumatology, Haematology, Urology, Oncology & Toxicology
12.1 Rheumatology: Gout, Osteoarthritis & Inflammatory Arthritis 12.2 Haematology: Anaemias & Blood Safety Monitoring 12.3 Urology & Men's Health 12.4 Oncology Support & Oral Anticancer Medicines 12.5 Toxicology & Poisoning Management
13 Monitoring: Clinical Review
13.1 Clinical Review Process 13.2 Interpreting Laboratory & Clinical Monitoring 13.3 Recommending Treatment Modifications
14 Monitoring: Safety & Adverse Drug Reactions
14.1 Adverse Drug Reactions & Reporting 14.2 Allergies, Sensitivities & Cross-Reactivity 14.3 High-Risk Medicines Monitoring
15 Compounding Medicines
15.1 Determining Required Formulations 15.2 Compounding Standards & Quality 15.3 Patient-Specific Preparations
16 Pharmaceutical Calculations
16.1 Dosage Calculations 16.2 Concentrations, Dilutions & Alligation 16.3 Half-Life & Basic Kinetic Calculations
17 Promote Health & Well-Being
17.1 National & Local Health Priorities 17.2 Screening Programs & Pharmacist Role 17.3 Culturally Responsive Promotion & Self-Sufficiency
11.2 Dermatology, Ophthalmology & ENT
Key Takeaways Explain This Topic AI
Topical corticosteroid potency must match site and severity: face/flexures and children need lower potency and shorter courses; counsel fingertip units, thin application, and steroid-phobia balance.
Acne care steps from benzoyl peroxide and topical retinoids to oral therapies; oral isotretinoin requires pregnancy-prevention program awareness and pharmacist safety vigilance.
Eczema flares prioritise emollients, trigger avoidance, and appropriate-potency topical steroids; infection or failure to respond needs medical review.
Bacterial conjunctivitis is usually self-limiting, but eye pain, photophobia, vision loss, trauma, or contact-lens red flags require urgent referral — do not treat serious eye disease as simple sticky eye.
Glaucoma drop technique, nasolacrimal occlusion, and systemic beta-blocker caution matter; allergic rhinitis is stepwise (allergen measures, intranasal corticosteroid, antihistamines); distinguish otitis externa from media at a high level.
Last updated: August 2026
11.2 Dermatology, Ophthalmology & ENT
Quick Answer: Match topical steroid potency to site and severity , build acne and eczema plans around evidence-based steps and red-flag infection, never miss painful red eye with vision change , teach glaucoma drop technique with systemic beta-blocker awareness, and use stepwise allergic rhinitis care while distinguishing otitis externa from media for referral urgency.
Dermatology, eye, and ENT presentations are frequent community pharmacy workloads and appear in APC Intern Written scenarios under Standards 3.1–3.3 . You must triage self-care versus referral, select appropriate OTC or prescribed therapy, counsel technique, and monitor adverse effects. AMH supports drug choice and cautions; APF supports counselling standards.
Topical corticosteroids — potency concepts and counselling
Topical corticosteroids reduce inflammation in eczema, contact dermatitis, psoriasis plaques (selected), and other steroid-responsive dermatoses. Australian practice groups products by potency (mild → moderate → potent → very potent). Exact brand rankings should be checked in AMH, but conceptual rules are stable:
Face, eyelids, flexures, genitals, and large areas in children: prefer mild potency (e.g. hydrocortisone 1% concepts) and short courses
Trunk and limbs with thicker plaques or severe flares: moderate to potent agents may be appropriate for limited duration under advice
Very potent steroids: specialist/short-course territory; high risk of atrophy and systemic absorption if misused
Counselling essentials:
Apply a thin layer to affected skin only
Use fingertip units (FTU) as a practical quantity guide (one FTU covers roughly two adult hand areas — teach the concept rather than over-precise arithmetic unless asked)
Emollients are foundational in dry/eczematous skin; apply liberally and often; leave a short gap if sequencing with steroids per product advice
Course length: use until control, then step down; avoid abrupt “scare-stop” that leaves disease untreated
Adverse effects of overuse: skin atrophy, striae, telangiectasia, perioral dermatitis, tachyphylaxis concerns, HPA-axis suppression with extensive potent use
Steroid phobia is common — balance safety counselling with the harm of undertreating moderate–severe eczema
Occlusion increases potency/absorption. Infection under an inflamed rash may need antimicrobial assessment rather than escalating steroid alone.
Acne — benzoyl peroxide, topical retinoids, oral isotretinoin awareness
Acne pathogenesis involves follicular hyperkeratinisation, sebum, Cutibacterium acnes , and inflammation. Community stepped care (high-level):
General measures: non-comedogenic products, gentle cleansing (avoid harsh scrubbing), realistic timelines (weeks, not days)
Benzoyl peroxide: antibacterial/keratolytic; can bleach fabrics; start lower strength to reduce irritation
Topical retinoids (e.g. adapalene concepts): normalise follicular turnover; counsel initial irritation, photosensitivity, and night application habits; contraception awareness for people who can become pregnant because systemic retinoid teratogenicity frames class caution even when topical exposure is lower
Topical antibiotics: stewardship — prefer combination with benzoyl peroxide where used to reduce resistance; avoid long monotherapy
- Oral antibiotics (prescribed): limited duration strategies; combine with topical non-antibiotic agents
- Hormonal options in suitable females; spironolactone concepts in selected cases under medical care
- Oral isotretinoin: for severe nodulocystic or treatment-resistant acne under specialist frameworks
Isotretinoin pregnancy program awareness is non-negotiable for pharmacists: major teratogen, mandatory contraception and pregnancy testing concepts, no sharing of capsules, dry skin/lips/eyes counselling, mood monitoring discussions as clinically framed, and interaction with vitamin A supplements. Even if you do not initiate therapy, dispensing and counselling must reinforce program rules.
Eczema flare care
Atopic eczema flares present with itch, dryness, and inflammation. Priority actions:
- Liberate emollient use (soap-free wash, frequent moisturiser)
- Identify triggers (soaps, wool, heat, allergens, infection)
- Apply appropriate-potency topical corticosteroid to inflamed areas for an adequate short course
- Antihistamines may help sleep when itch disturbs rest; they do not treat the skin inflammation itself
Watch for infected eczema (crusting, weeping, rapid worsening, fever) → medical review; antiviral caution if herpetic eczema suspected
Failure of standard care, facial/eyelid disease needing more than mild steroid, or significant sleep loss/infection risk warrants GP or dermatology pathways.
Bacterial conjunctivitis versus red-flag eye disease
Typical bacterial conjunctivitis: sticky discharge, redness, gritty sensation, often bilateral sequential spread, vision usually preserved. Many cases are self-limiting; hygiene (no sharing towels, discard eye cosmetics) matters. Chloramphenicol eye drops/ointment are familiar Australian pharmacist-supply options within protocol for appropriate presentations — still assess red flags first.
Red flags — urgent medical/ophthalmology care, not routine OTC pathways:
- Moderate–severe eye pain (not just grittiness)
- Photophobia
- Reduced or blurred vision , halos, visual field loss
- Recent trauma, chemical exposure, or foreign body
- Contact lens wear with red eye (risk of microbial keratitis)
- Vesicular rash around the eye (herpes zoster ophthalmicus concern)
- Severe headache with eye symptoms, pupil changes, or proptosis
- Neonatal red eye
Do not let “pink eye” language hide acute angle-closure glaucoma, uveitis, keratitis, or orbital cellulitis. When in doubt, refer urgently.
Glaucoma drops — technique and systemic beta-blocker caution
Chronic open-angle glaucoma is often treated with topical agents (prostaglandin analogues, beta-blockers, carbonic anhydrase inhibitors, alpha-agonists — know class concepts). Pharmacist counselling focuses on technique and adherence :
Wash hands; shake suspensions if required
Tilt head, pull down lower lid, instil one drop into the conjunctival sac without touching the eye with the bottle tip
Close eye gently; use nasolacrimal occlusion (pressure at inner corner) for 1–2 minutes to reduce systemic absorption and improve local effect
Space different drops by several minutes
Counsel expected effects (e.g. iris darkening/lash growth with prostaglandins) and adherence despite asymptomatic disease
Systemic beta-blocker caution: timolol and related topical beta-blockers can be absorbed enough to cause bradycardia, bronchospasm, or fatigue in susceptible people — caution in asthma/COPD and heart block history. Flag duplicate systemic beta-blocker load. Report breathing difficulty or marked bradycardia symptoms for medical review.
Allergic rhinitis — stepwise care
Allergic rhinitis (seasonal or perennial) features sneezing, rhinorrhoea, nasal itch, and congestion, often with allergic conjunctivitis.
Stepwise approach:
Allergen reduction where practical (bedding covers, pet measures, pollen timing)
Intranasal corticosteroids as highly effective first-line for persistent moderate symptoms — counsel correct spray direction (away from septum), regular use for days–weeks for full benefit, and epistaxis precautions
- Oral non-sedating antihistamines for itch/sneeze-predominant symptoms
- Intranasal antihistamines or combination products in selected cases
- Saline irrigation as supportive care
Short courses of oral decongestants or topical decongestants with strict limits to avoid rhinitis medicamentosa
Refer for unilateral persistent blockage, blood-stained discharge, severe facial pain, or poor response suggesting chronic rhinosinusitis or other pathology.
Otitis externa versus otitis media (high-level)
- Feature Otitis externa (“swimmer’s ear”) Otitis media
- Main site Ear canal skin Middle ear behind tympanic membrane
Typical clues Pain on moving pinna/tragus, itch, discharge, recent water exposure Earache with systemic URTI context, especially in children; fever common
Community care themes Keep dry, analgesic, topical therapy when appropriate after assessment Analgesia; antibiotics only when guidelines support bacterial AOM treatment — stewardship
Red flags Severe pain, fever, cellulitis, diabetes/immunocompromise with malignant OE risk Mastoiditis signs, under 6 months, systemically unwell, persistent perforation concerns
Do not put drops in the ear if tympanic membrane integrity is uncertain without clinical advice. Distinguish pain origin: canal tenderness points to externa; systemic childhood AOM patterns point to media and often medical assessment.
- Integrated safety habits
- Match steroid potency to skin site; pair with emollients in eczema
- Acne: benzoyl peroxide/retinoid foundations before escalating; isotretinoin = pregnancy program
- Eyes: vision/pain/photophobia/contact lens = escalate
- Glaucoma: technique + systemic beta-blocker risk
- Nose/ear: stepwise rhinitis; externa vs media triage
These patterns convert common counter presentations into safe, exam-ready clinical decisions.